Skip to content
mesothelioma chemotherapy

Mesothelioma Chemotherapy Journal Articles

Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.

Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability

Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations

Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma.

Cancer and bacteria

Many experts say that germs have the ability to make the body adjust and learn about the fighting back mechanism against tumors.

A Pill Card for keeping track of your meds

molecular diagram   This is a Microsoft Word document developed at the Agency for Healthcare Research and Quality. We like it.

 

 

 

This website is sponsored by Jonathan David* of The David Law Firm. The David Law Firm is located in The Woodlands, Texas (Greater Houston Area) and can be reached toll free at 1-800-998-9729 for more information on mesothelioma. Jonathan David is not a medical doctor. The information on these pages is for the education of mesothelioma patients and their families regarding potential medical and legal options. Patients are advised to consult with a medical doctor.

*  Licensed by the Supreme Court  of Texas.

 

 

 

The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a clinical practice guideline.

Advances in the systemic therapy of malignant pleural mesothelioma

Kinase Inhibitors for Mesothelioma Treatment

journal abstracts

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

The second wave in kinase cancer drugs

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma


Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.